{
    "organizations": [],
    "uuid": "4550d8b1554ae46cd752cdb41fa1fbb1ee1f6c5b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-achaogen-announces-upgraded-status/brief-achaogen-announces-upgraded-status-for-plazomicin-fill-manufacturer-idUSFWN1PP193",
    "ord_in_thread": 0,
    "title": "BRIEF-Achaogen Announces Upgraded Status For Plazomicin Fill Manufacturer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 30, 2018 / 3:48 PM / in 14 minutes BRIEF-Achaogen Announces Upgraded Status For Plazomicin Fill Manufacturer Reuters Staff 1 Min Read \nJan 30 (Reuters) - Achaogen Inc: \n* SAYS ‍FDA CLASSIFIED OUTCOME OF ITS Q4 2017 REINSPECTION OF PFIZER‘S MCPHERSON FACILITY AS VOLUNTARY ACTION INDICATED​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-30T17:48:00.000+02:00",
    "crawled": "2018-01-30T18:17:17.031+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "announces",
        "upgraded",
        "status",
        "plazomicin",
        "fill",
        "manufacturer",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "achaogen",
        "inc",
        "say",
        "classified",
        "outcome",
        "q4",
        "reinspection",
        "pfizer",
        "mcpherson",
        "facility",
        "voluntary",
        "action",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}